Suchergebnisse - "Kabil, Mohamed Fawzi"

PubPharm (8)

1

Folic/lactobionic acid dual-targeted polymeric nanocapsules for potential treatment of hepatocellular carcinoma

enthalten in: Drug delivery and translational research | 2024

von Kabil, M. | Gaber, S. | Hamzawy, M. | +2

2

Recent progress on polySarcosine as an alternative to PEGylation : Synthesis and biomedical applications

enthalten in: International journal of pharmaceutics | 2024

von Kabil, M. | Azzazy, H. | Nasr, M.

3

Potential anticancer effect of free and nanoformulated Deferasirox for breast cancer treatment : in-vitro and in-vivo evaluation

enthalten in: Drug development and industrial pharmacy | 2024

von Abdel-Wahab, N. | Kabil, M. | El-Sherbiny, I. | +3

4

A comprehensive review on lipid nanocarrier systems for cancer treatment : fabrication, future prospects and clinical trials

enthalten in: Journal of liposome research | 2024

von Kabil, M. | Badary, O. | Bier, F. | +2

5

Deferasirox : A comprehensive drug profile

enthalten in: Profiles of drug substances, excipients, and related methodology | 2024

von Kabil, M. | Nasr, M.

6

Folic/lactobionic acid dual-targeted polymeric nanocapsules for potential treatment of hepatocellular carcinoma

enthalten in: Drug Delivery and Translational Research | 2023

von Kabil, M. | Gaber, S. | Hamzawy, M. | +2

7

Switching indication of PEGylated lipid nanocapsules-loaded with rolapitant and deferasirox against breast cancer : Enhanced in-vitro and in-vivo cytotoxicity

enthalten in: Life sciences | 2022

von Kabil, M. | Mahmoud, M. | Bakr, A. | +2

8

New repurposed rolapitant in nanovesicular systems for lung cancer treatment : Development, in-vitro assessment and in-vivo biodistribution study

enthalten in: European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences | 2022

von Kabil, M. | Nasr, M. | Ibrahim, I. | +2

1
[1]